| ALNA Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ALNA shares outstanding history going back to 11/2/2017:
Also see: ALNA Market Cap History ALNA YTD Return |
ALNA Shares Outstanding History — Allena Pharmaceuticals Share Count Over Time
As of 8/12/2022 Allena Pharmaceuticals has 122.08 million ALNA shares outstanding. Investors often track the ALNA shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ALNA share count trends over time, with 24 historical shares outstanding datapoints presented, dating back to 11/2/2017.
| ALNA Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||
ALNA Historical Shares Outstanding: +45.09% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| ALNA Stock Price Chart |
| About Allena Pharmaceuticals Inc |
| Allena Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing oral enzyme therapeutics to treat patients with metabolic and kidney disorders. Co. is focused on metabolic disorders that result in excess accumulation of certain metabolites that stimulate inflammation, damage the kidney, and potentially lead to chronic kidney disease (CKD), and end-stage renal disease. Co.'s product candidate, ALLN-346, is an orally administered, urate degrading enzyme for patients with hyperuricemia and gout in the setting of improved CKD. Co. has conducted a Phase 1 program, including both a single-ascending dose and multiple-ascending dose study in healthy volunteers. We show 24 historical shares outstanding datapoints in our coverage of ALNA's shares outstanding history. Understanding the changing numbers of ALNA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ALNA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ALNA by allowing them to research ALNA shares outstanding history as well as any other stock in our coverage universe. |
| ALNA Current Stock Quote |
Quotes delayed 20 minutes  Free ALNA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ALNA Share Performance |
| Shares Outstanding Peers |
| Allena Pharmaceuticals (ALNA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ALNY Shares Outstanding History ALOG Shares Outstanding History ALPN Shares Outstanding History ALQA Shares Outstanding History ALRN Shares Outstanding History ALT Shares Outstanding History ALTS Shares Outstanding History ALUR Shares Outstanding History ALVR Shares Outstanding History ALXN Shares Outstanding History More Healthcare companies » |
ALNA Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
